Embecta Rallies After UK Firm Deal Worth $200 Million

This strategic move aims to enhance Embecta’s capabilities in drug-delivery systems.Deal Valued At Up To $200 MillionEmbecta values the acquisition at up to 150 million pounds (around $200.1 million). That includes an upfront cash payment of 100 million pounds and potential performance-based payments of up to 50 million pounds.Owen Mumford generated net revenue of 69.4 million pounds during its fiscal year 2025, and Embecta expects to close the deal in its fiscal third quarter of 2026, pending regulatory ap ...